日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs

评估溶解度限制吸收作为预测 BCS II/IV 类药物食物效应的替代指标

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-025-01473-9
Rodriguez-Fernandez, Karine; Gómez-Mantilla, José David; Shukla, Suneet; Stopfer, Peter; Sieger, Peter; Mangas-Sanjuán, Victor; Peters, Sheila Annie
发表日期：2025
文献求助 收藏

Highly Sensitive Multiplexed Detection of Brain‐Derived Tau and Phosphorylated Tau Proteoforms with the NULISA Technology

利用NULISA技术对脑源性tau蛋白和磷酸化tau蛋白进行高灵敏度多重检测

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-33613-3
Wang, Yi-Jun; Patel, Bhargav A; Anreddy, Nagaraju; Zhang, Yun-Kai; Zhang, Guan-Nan; Alqahtani, Saeed; Singh, Satyakam; Shukla, Suneet; Kaddoumi, Amal; Ambudkar, Suresh V; Talele, Tanaji T; Chen, Zhe-Sheng; Ma, Xiao‐Jun; Iyengar, Shweta; Deshmukh, Shalaka; Comandor, Roopa; Wang, Li; Kim, Sean; Xu, Xiaomei; Feng, Wei; Qiu, Xiaolei; Zhang, Bingqing; Luo, Yuling
信号转导
磷酸化
神经科学
发表日期：2025
文献求助 收藏

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells

Selonsertib (GS-4997) 是一种 ASK1 抑制剂，可拮抗 ABCB1 和 ABCG2 过表达癌细胞的多药耐药性。

期刊:Cancer Letters
影响因子:10.1
doi:10.1016/j.canlet.2018.10.007
Ji, Ning; Yang, Yuqi; Cai, Chao-Yun; Lei, Zi-Ning; Wang, Jing-Quan; Gupta, Pranav; Shukla, Suneet; Ambudkar, Suresh V; Kong, Dexin; Chen, Zhe-Sheng
ABCG2
肿瘤
肿瘤免疫
ABCB1
细胞生物学
发表日期：2019
文献求助 收藏

Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer

瑞戈非尼拮抗结肠癌中BCRP介导的多药耐药性

期刊:Cancer Letters
影响因子:10.1
doi:10.1016/j.canlet.2018.10.032
Zhang, Yun-Kai; Wang, Yi-Jun; Lei, Zi-Ning; Zhang, Guan-Nan; Zhang, Xiao-Yu; Wang, De-Shen; Al-Rihani, Sweilem B; Shukla, Suneet; Ambudkar, Suresh V; Kaddoumi, Amal; Shi, Zhi; Chen, Zhe-Sheng
肿瘤
肠癌
肿瘤免疫
CRP
BCR
发表日期：2019
文献求助 收藏

Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells

格列沙替尼（Glesatinib）是一种c-MET/SMO双重抑制剂，可拮抗癌细胞中P-糖蛋白介导的多药耐药性。

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2019.00313
Cui, Qingbin; Cai, Chao-Yun; Gao, Hai-Ling; Ren, Liang; Ji, Ning; Gupta, Pranav; Yang, Yuqi; Shukla, Suneet; Ambudkar, Suresh V; Yang, Dong-Hua; Chen, Zhe-Sheng
SMO
肿瘤
肿瘤免疫
细胞生物学
MET
发表日期：2019
文献求助 收藏

Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.

瑞戈非尼克服了由 ABCB1 转运体介导的结直肠癌化疗多药耐药性：体外和体内研究

期刊:Cancer Letters
影响因子:10.1
doi:10.1016/j.canlet.2017.03.011
Wang Yi-Jun, Zhang Yun-Kai, Zhang Guan-Nan, Al Rihani Sweilem B, Wei Meng-Ning, Gupta Pranav, Zhang Xiao-Yu, Shukla Suneet, Ambudkar Suresh V, Kaddoumi Amal, Shi Zhi, Chen Zhe-Sheng
肿瘤
肠癌
发表日期：2017
文献求助 收藏

Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions

去垢剂胶束环境对P-糖蛋白（ABCB1）-配体相互作用的影响

期刊:Journal of Biological Chemistry
影响因子:3.9
doi:10.1074/jbc.M116.771634
Shukla, Suneet; Abel, Biebele; Chufan, Eduardo E; Ambudkar, Suresh V
ABCB1
发表日期：2017
文献求助 收藏

Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1

噻唑-缬氨酸肽模拟物（TTT-28）通过选择性抑制ABCB1的外排活性，在体外和体内拮抗多药耐药性。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/srep42106
Wang, Yi-Jun; Patel, Bhargav A; Anreddy, Nagaraju; Zhang, Yun-Kai; Zhang, Guan-Nan; Alqahtani, Saeed; Singh, Satyakam; Shukla, Suneet; Kaddoumi, Amal; Ambudkar, Suresh V; Talele, Tanaji T; Chen, Zhe-Sheng
ABCB1
发表日期：2017
文献求助 收藏

Crystal structure of the antigen-binding fragment of a monoclonal antibody specific for the multidrug-resistance-linked ABC transporter human P-glycoprotein

针对多药耐药相关ABC转运蛋白人P-糖蛋白的单克隆抗体抗原结合片段的晶体结构

期刊:Acta Crystallographica Section F-Structural Biology Communications
影响因子:1.1
doi:10.1107/S2053230X16009778
Esser, Lothar; Shukla, Suneet; Zhou, Fei; Ambudkar, Suresh V; Xia, Di
单克隆抗体
发表日期：2016
文献求助 收藏

Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.

Motesanib (AMG706) 是一种强效的多激酶抑制剂，它通过抑制 ABCB1 的外排活性来拮抗多药耐药性

期刊:Biochemical Pharmacology
影响因子:5.6
doi:10.1016/j.bcp.2014.06.006
Wang Yi-Jun, Kathawala Rishil J, Zhang Yun-Kai, Patel Atish, Kumar Priyank, Shukla Suneet, Fung King Leung, Ambudkar Suresh V, Talele Tanaji T, Chen Zhe-Sheng
信号转导
发表日期：2014
文献求助 收藏